The WHO Model List of Essential Medicines for Children (aka Essential Medicines List for Children or EMLc), published by the World Health Organization (WHO), contains the medications considered to be most effective and safe in children up to twelve years of age to meet the most important needs in a health system.
The list is divided into core items and complementary items. The core items are deemed to be the most cost-effective options for key health problems and are usable with little additional health care resources. The complementary items either require additional infrastructure such as specially trained health care providers or diagnostic equipment or have a lower cost–benefit ratio.
The first list for children was created in 2007, and the list is in its 8th edition .
Note: An α indicates a medicine is only on the complementary list.
Anaesthetics, preoperative medicines and medical gases
General anaesthetics and oxygen
Inhalational medicines
Halothane
Isoflurane
Nitrous oxide
Oxygen
Injectable medicines
Ketamine
Propofol
Local anaesthetics
Bupivacaine
Lidocaine
Lidocaine/epinephrine (lidocaine + epinephrine)
Preoperative medication and sedation for short-term procedures
Atropine
Midazolam
Morphine
Medical gases
Oxygen
Medicines for pain and palliative care
Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) Ibuprofen Paracetamol (acetaminophen)
Opioid analgesics
Morphine
Methadone
Medicines for other symptoms common in palliative care
Amitriptyline
Cyclizine
Dexamethasone
Diazepam
Docusate sodium
Fluoxetine
Hyoscine hydrobromide
Lactulose
Midazolam
Ondansetron
Senna
Antiallergics and medicines used in anaphylaxis
Dexamethasone
Epinephrine (adrenaline) Hydrocortisone Loratadine Prednisolone
Antidotes and other substances used in poisonings
Non-specific
Charcoal, activated
Specific
Acetylcysteine
Atropine
Calcium gluconate
Naloxone
Deferoxamine
Dimercaprol
Fomepizole
Sodium calcium edetate
Succimer
Anticonvulsants/antiepileptics
Carbamazepine
Diazepam
Lamotrigine
Lorazepam
Midazolam
Phenobarbital
Phenytoin
Valproic acid (sodium valproate) Ethosuximide Valproic acid (sodium valproate)
Anti-infective medicines
Anthelminthics
Intestinal anthelminthics
Albendazole
Ivermectin
Levamisole
Mebendazole
Niclosamide
Praziquantel
Pyrantel
Antifilarials
Albendazole
Diethylcarbamazine
Ivermectin
Antischistosomals and other antinematode medicines
Praziquantel
Triclabendazole
Oxamniquine
Cysticidal medicines
Albendazole
Mebendazole
Praziquantel
Antibacterials
Access group antibiotics
Amikacin
Amoxicillin
Amoxicillin/clavulanic acid (amoxicillin + clavulanic acid) Ampicillin Benzathine benzylpenicillin Benzylpenicillin Cefalexin Cefazolin Chloramphenicol Clindamycin Cloxacillin Doxycycline Gentamicin Metronidazole Nitrofurantoin Phenoxymethylpenicillin (penicillin V) Procaine benzylpenicillin Sulfamethoxazole/trimethoprim (sulfamethoxazole + trimethoprim) Trimethoprim
Watch group antibiotics
Azithromycin
Cefixime
Cefotaxime
Ceftriaxone
Cefuroxime
Ciprofloxacin
Clarithromycin
Piperacillin/tazobactam (piperacillin + tazobactam) Vancomycin Ceftazidime Meropenem Vancomycin
Reserve group antibiotics
Reserve antibiotics are last-resort antibiotics. The EML antibiotic book was published in 2022.
Ceftazidime/avibactam (ceftazidime + avibactam) Colistin Fosfomycin Linezolid Polymyxin B
Antileprosy medicines
Clofazimine
Dapsone
Rifampicin
Antituberculosis medicines
Ethambutol
Isoniazid
Isoniazid/pyrazinamide/rifampicin (isoniazid + pyrazinamide + rifampicin) Isoniazid/rifampicin (isoniazid + rifampicin) Isoniazid/rifapentine (isoniazid + rifapentine) Pyrazinamide Rifampicin Rifapentine Amikacin Amoxicillin/clavulanic acid (amoxicillin + clavulanic acid) Bedaquiline Clofazimine Cycloserine Delamanid Ethionamide Levofloxacin Linezolid Meropenem Moxifloxacin P-aminosalicylic acid Streptomycin